Skip to main content
Premium Trial:

Request an Annual Quote

Strand Gets Investment from Burrill

NEW YORK (GenomeWeb News) – Strand Life Sciences today said that financial services firm Burrill & Co. has invested in the firm's Series B round of financing.

The amount of Burrill's investment is not being disclosed by the Bangalore, India-based bioinformatics firm. However, Strand noted that the financing included both a primary investment into the firm and a secondary buy-out of the lead investors from its Series A round.

Strand said that it will use the funds to accelerate its growth in the diagnostics market and expand its global reach. In particular, it cited its efforts to apply next-generation sequencing data to screening and identification of diseases and personalized medicine.

Though known primarily for its bioinformatics offerings, last year Strand inked a licensing deal to offer Trovagene's human papillomavirus urine test and high-risk HPV DNA assay in India and countries in the South Asian Association for Regional Cooperation for clinical diagnostic and carrier screening applications.

"Strand is strongly positioned to play a pivotal role in the transformation of healthcare due to the convergence of information technology and life sciences," David Wetherell, president and COO of Burrill Healthcare Venture and Private Equity Funds, said in a statement.

Burrill was the sole investor in the Series B round.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.